ATTIRE: Albumin To prevenT Infection in chronic liveR failurE: study protocol for a single-arm feasibility trial.

Louise ChinaNicola MuirheadSimon S SkeneZainib ShabirRoel P H De MaeyerAlexander A N MainiDerek W GilroyAlastair J O'Brien

Published in: BMJ open (2016)

The trial is registered with the European Medicines Agency (EudraCT 2014-002300-24) and has been adopted by the NIHR (ISRCTN 14174793). This manuscript refers to V.4.0 of the protocol; Pre-results.

Keyphrases

liver failure
phase iii
study protocol
phase ii
hepatitis b virus
clinical trial
randomized controlled trial
open label
drug induced